164 related articles for article (PubMed ID: 33854487)
1. Methods and Techniques to Facilitate the Development of
Dailey KM; Jacobson RI; Johnson PR; Woolery TJ; Kim J; Jansen RJ; Mallik S; Brooks AE
Front Microbiol; 2021; 12():624618. PubMed ID: 33854487
[TBL] [Abstract][Full Text] [Related]
2. An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
Dailey KM; Small JM; Pullan JE; Winfree S; Vance KE; Orr M; Mallik S; Bayles KW; Hollingsworth MA; Brooks AE
PLoS One; 2023; 18(11):e0289183. PubMed ID: 37963142
[TBL] [Abstract][Full Text] [Related]
3. The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering.
Dailey KM; Allgood JE; Johnson PR; Ostlie MA; Schaner KC; Brooks BD; Brooks AE
Future Microbiol; 2021 Mar; 16(5):341-368. PubMed ID: 33754804
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of
Sharafabad BE; Abdoli A; Abdolmohammadi Khiav L; Meskini M; Jamur P; Dilmaghani A
Curr Cancer Drug Targets; 2023; 23(9):682-696. PubMed ID: 37069721
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil depletion enhanced the
Staedtke V; Gray-Bethke T; Liu G; Liapi E; Riggins GJ; Bai RY
Neurooncol Adv; 2022; 4(1):vdab184. PubMed ID: 35118381
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors.
Feng X; He P; Zeng C; Li YH; Das SK; Li B; Yang HF; Du Y
Oncol Lett; 2021 Feb; 21(2):110. PubMed ID: 33376543
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
8. Learning from
Wang L; Wang Q; Tian X; Shi X
J Cancer Res Ther; 2018; 14(Supplement):S1-S6. PubMed ID: 29578142
[TBL] [Abstract][Full Text] [Related]
9. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
10. Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery.
Theys J; Patterson AV; Mowday AM
Mol Diagn Ther; 2024 Mar; 28(2):141-151. PubMed ID: 38302842
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
Wang S; Dong S; Wang P; Tao Y; Wang Y
Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
[No Abstract] [Full Text] [Related]
12. Multifunctional porous microspheres encapsulating oncolytic bacterial spores and their potential for cancer immunotherapy.
Bae GH; Ryu YH; Han J; Kim SH; Park CG; Park JH; Kim DH; Chon HJ; Kim C; Choi SW; Park W
Biomater Sci; 2023 Jun; 11(13):4652-4663. PubMed ID: 37218418
[No Abstract] [Full Text] [Related]
13. The oncolytic activity of
Abedi Jafari F; Abdoli A; Pilehchian R; Soleimani N; Hosseini SM
Bioimpacts; 2022; 12(5):405-414. PubMed ID: 36381634
[No Abstract] [Full Text] [Related]
14. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses.
Roberts NJ; Zhang L; Janku F; Collins A; Bai RY; Staedtke V; Rusk AW; Tung D; Miller M; Roix J; Khanna KV; Murthy R; Benjamin RS; Helgason T; Szvalb AD; Bird JE; Roy-Chowdhuri S; Zhang HH; Qiao Y; Karim B; McDaniel J; Elpiner A; Sahora A; Lachowicz J; Phillips B; Turner A; Klein MK; Post G; Diaz LA; Riggins GJ; Papadopoulos N; Kinzler KW; Vogelstein B; Bettegowda C; Huso DL; Varterasian M; Saha S; Zhou S
Sci Transl Med; 2014 Aug; 6(249):249ra111. PubMed ID: 25122639
[TBL] [Abstract][Full Text] [Related]
15.
Staedtke V; Roberts NJ; Bai RY; Zhou S
Genes Dis; 2016 Jun; 3(2):144-152. PubMed ID: 30258882
[TBL] [Abstract][Full Text] [Related]
16. Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging-Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models.
Ji J; Park WR; Cho S; Yang Y; Li W; Harris K; Huang X; Gu S; Kim DH; Zhang Z; Larson AC
J Vasc Interv Radiol; 2019 Jul; 30(7):1106-1115.e1. PubMed ID: 30952520
[TBL] [Abstract][Full Text] [Related]
17. Gene Editing in Clinical Practice: Where are We?
Mittal RD
Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
[TBL] [Abstract][Full Text] [Related]
18. In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing.
Liu Y; Tao W; Wen S; Li Z; Yang A; Deng Z; Sun Y
mBio; 2015 Nov; 6(6):e01714-15. PubMed ID: 26556277
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas12a-Mediated Gene Deletion and Regulation in
Zhao R; Liu Y; Zhang H; Chai C; Wang J; Jiang W; Gu Y
ACS Synth Biol; 2019 Oct; 8(10):2270-2279. PubMed ID: 31526005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
